SIGN UP
LOG IN
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·07/29/2025 17:06:19
Listen to the news
Gainers
- Durect (NASDAQ:DRRX) stock moved upwards by 238.3% to $1.87 during Tuesday's regular session. The market value of their outstanding shares is at $17.1 million.
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares increased by 59.3% to $1.18. The market value of their outstanding shares is at $1.5 million.
- Calidi Biotherapeutics (AMEX:CLDI) shares rose 29.03% to $0.71. The company's market cap stands at $18.9 million.
- Moleculin Biotech (NASDAQ:MBRX) shares rose 25.74% to $0.69. The market value of their outstanding shares is at $16.6 million.
- Sarepta Therapeutics (NASDAQ:SRPT) shares increased by 19.73% to $16.59. The market value of their outstanding shares is at $1.3 billion.
- Exagen (NASDAQ:XGN) shares rose 16.91% to $8.64. The company's market cap stands at $161.5 million. As per the news, the Q2 earnings report came out today.
Losers
- AIM ImmunoTech (AMEX:AIM) shares fell 53.8% to $3.33 during Tuesday's regular session. The company's market cap stands at $5.5 million.
- Ekso Bionics Holdings (NASDAQ:EKSO) stock fell 26.05% to $3.35. The market value of their outstanding shares is at $10.7 million. The company's, Q2 earnings came out yesterday.
- NeoGenomics (NASDAQ:NEO) shares declined by 24.77% to $4.86. The market value of their outstanding shares is at $831.3 million. As per the press release, Q2 earnings came out today.
- ProPhase Labs (NASDAQ:PRPH) stock fell 21.96% to $0.35. The company's market cap stands at $18.4 million.
- Sonnet BioTherapeutics (NASDAQ:SONN) shares decreased by 21.42% to $3.18. The market value of their outstanding shares is at $25.3 million.
- Kindly MD (NASDAQ:NAKA) shares declined by 21.35% to $8.33. The company's market cap stands at $80.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.